From $2.6 Trillion to Below IPO Price in Six Weeks

The June 19 article on Solara Times captured SpaceX at the moment of maximum euphoria. The company had surged past $2.6 trillion in market capitalization within days of its Nasdaq debut, overtaking Tesla and Meta, prompting Wall Street strategists to debate whether the Magnificent Seven label needed replacing.

The update those numbers require is significant. As of July 27, 2026, SPCX is trading at $113.50, with a 52-week range of $108.66 to $225.64. SpaceX's market capitalization stands at approximately $1.52 trillion as of July 24, a decrease of 14.12% from its $1.77 trillion IPO valuation, and more than 40% below the $2.64 trillion peak it reached on June 16. The stock has erased over $1 trillion in market value from its peak.

SpaceX shares debuted at $135 on June 12, surged above $225 during its first week of trading, but have since fallen more than 50% from their peak. SPCX fell 3% on Friday to $115.07, extending its weekly loss to 7% and marking a third consecutive week in the red. On July 27, SPCX touched an intraday all-time low of $110.21.

The Magnificent Seven debate has not disappeared. It has simply been overtaken by a more immediate question: whether SpaceX can justify any premium above its IPO price before two of the most consequential events in its brief public life arrive simultaneously.

August 4: The First Earnings Report

SpaceX is set to release its first quarterly earnings report as a public company on August 4, 2026, after market close. The disclosure will be the first time public investors see full quarterly financial results from a company they have been pricing at between $1.5 trillion and $2.6 trillion for the past six weeks.

Analysts expect revenue near $6.9 billion and a per-share loss of between $0.22 and $0.28. The revenue estimate is consistent with the company's 2025 trajectory ($18.7 billion in full-year revenue implies a quarterly run-rate of approximately $4.7 billion, suggesting analysts expect meaningful sequential acceleration), but the loss estimate reflects ongoing pressure from xAI capital spending.

AI-related capital spending jumped to $7.7 billion in the first quarter alone, roughly triple the prior year. Morgan Stanley analysts estimate xAI could burn through up to $120 billion in cash between 2026 and 2027. That figure, against 2025 full-year revenue of $18.7 billion, defines the financial tension at the heart of the SpaceX investment thesis: the company is spending on AI infrastructure at a pace that dwarfs its existing revenue base.

The market will closely scrutinize four areas: Starlink's profitability trajectory, Falcon 9 cash flow, xAI computing infrastructure spending, and whether financial guidance justifies the company's valuation. Starlink, which accounted for approximately 60% of 2025 revenue, is the only segment currently generating meaningful operating cash flow. Its subscriber count and average revenue per user will be the numbers that move the stock on earnings day.

August 6: The Lockup That Could Change Everything

Two trading days after the earnings report, SpaceX faces what may be the most consequential single day in its brief public history. A massive lockup expiry will release up to 911.5 million insider shares worth approximately $109.2 billion, a potential overhang exceeding the total amount raised in the IPO itself.

SpaceX built an unusual lockup structure into its IPO, one that lets insiders start selling stock earlier than the standard 180-day wait most newly public companies use. The first release of eligible shares happens on the second full trading day after the first earnings report. That accelerated structure was unusual at the time of the IPO and is now the dominant short-term risk factor for the stock.

HSBC analysts Nicolas Cote-Colisson and Charlie Rothbarth provided clients with a detailed roadmap of the expiration schedule. The first major release makes approximately 912 million shares eligible for sale on August 6. A second release event could occur on the same day depending on whether SPCX traded above $175.50 for at least five of the ten consecutive trading days ending August 4, a threshold the stock has not approached since late June.

Morgan Stanley analyst Adam Jonas acknowledged that many investors expect SpaceX shares to fall to $100 as lockup restrictions begin expiring. His response: if SPCX reached $100, it would be pricing in "little or no value for its AI business while also undervaluing its space launch and connectivity businesses." His Overweight rating and $300 price target remain in place. The market, trading the stock at $113.50, is effectively betting that the lockup expiration and earnings print together will determine which analyst is right.

At least one institutional trading desk has indicated it plans to wait for the lockup expirations before starting a position in the stock. That posture, sitting on the sidelines until the float expands, is likely widespread enough to explain why the stock has not found durable buying support above its IPO price despite an analyst consensus price target above $230.

What Actually Broke: Starship and the Falcon 9 Pivot

The original article identified Starship delays and the Falcon 9-to-Starship transition as risk factors. Both have since materialized in ways that directly affected investor confidence.

The 13th Starship test flight, originally scheduled for July 16, was automatically aborted before liftoff after four of the Super Heavy booster's 33 Raptor engines failed to start normally. Musk stated that two engines would be replaced, targeting a new attempt on July 23. Subsequently, on July 20, a Falcon 9 mission to deploy Starlink satellites was also halted at the last moment after ignition, marking the second recent launch abort in rapid succession.

The July 24 flight eventually proceeded. Morgan Stanley gave Starship Flight 13 an A- grade. The mission saw all 33 Raptor engines fire cleanly, completed hot-stage separation, deployed 20 production Starlink V3 satellites, relit a Raptor engine in space, and achieved its softest splashdown to date, though the Super Heavy V3 booster had a hard splashdown rather than a controlled catch.

The operational context around the Starship transition adds a separate medium-term pressure. SpaceX has reportedly turned away dedicated Falcon 9 customers beyond 2028 as it moves more attention toward Starship. That strategic pivot makes fundamental sense if Starship's cost reduction thesis proves out; the bull case projects launch costs falling to approximately 10% of Falcon 9's per-orbital-launch cost at full reusability. It creates near-term revenue risk if the transition takes longer than scheduled.

Greg Pendy, space industry analyst at Clear Street Research, put it directly: "Starship underpins both SpaceX's connectivity and AI businesses. Any delay means the overall growth narrative gets pushed back."

The Analyst Divide: $62 to $800

The original article noted wide analyst disagreement on SpaceX's valuation. That disagreement has only sharpened as the stock has pulled back.

HSBC initiated coverage with a Hold rating and a $115 price target, citing caution on valuing long-term opportunities such as space-based data centers and the lunar economy while acknowledging SpaceX remains the clear leader in commercial space launches. HSBC analyst Nicolas Cote-Colisson noted the potential selling pressure from lockup expirations as a specific near-term concern.

Morgan Stanley's Adam Jonas maintained his Overweight rating and $300 target, describing SpaceX as "uniquely positioned across launch, connectivity, and AI." His note argued that current prices undervalue all three segments simultaneously and that the lockup expiration, while a near-term headwind, does not change the multi-year investment case.

Out of 33 analysts covering SPCX, 22 recommend Strong Buy, two recommend Moderate Buy, eight recommend Hold, and one recommends Sell. The average price target is $231.83, implying over 100% upside from current levels. The spread from $62 to $800 across individual analyst targets reflects genuine disagreement about which scenario, a Starship-enabled cost revolution or a prolonged high-multiple loss-making period, is the right base case.

Morningstar's assessment sits between the extremes: SpaceX has transformed the economics of space launch and dominates the market for lifting spacecraft into orbit with a decade lead on most competitors, but its aggressively lofty valuation implies investors will have to wait decades for earnings to grow into SpaceX's multiples.

Short sellers have made a directed bet on that mismatch. Bearish investors have accumulated roughly $15.5 billion in unrealized gains following the June public offering, one of the largest short-position profit pools against any newly public stock in market history.

What the Magnificent Seven Question Looks Like Now

The original article asked whether SpaceX's IPO-week surge above Tesla and Meta warranted retiring or expanding the Magnificent Seven label. That question has a more concrete answer six weeks later.

SpaceX at $1.52 trillion is no longer above Meta. It is roughly in line with Tesla at their current levels, having surrendered the brief valuation lead that sparked the Magnificent Seven debate. The "FAB 10" and "MANGOS" frameworks floated by Vanda Research and others during IPO week have quieted as SpaceX's stock price has converged back toward the lower end of where pre-IPO shadow markets priced it.

The more durable structural question raised by Morningstar is what happens to SpaceX's index weighting as the public float expands through lockup expirations. The August 6 share unlock could significantly increase the company's weight in major index funds, including QQQ-linked products, even without a corresponding increase in stock price, a technical consequence of float expansion that could generate passive buying inflows independent of fundamental sentiment.

Conclusion: Seven Days That Will Define SPCX

The SpaceX story has moved from IPO euphoria into the first real test of whether its financial profile can sustain a multi-trillion-dollar valuation. The August 4 earnings report will answer questions that the S-1 filing raised but could not resolve: how fast Starlink is growing, how much xAI is consuming, and whether any credible path to profitability exists within a reasonable investment horizon.

The August 6 lockup expiration will answer a separate and equally important question: how many of the 911.5 million newly eligible shareholders choose to sell, and at what price the market clears that supply. If earnings are strong and sellers are patient, the combination could stabilize the stock above its IPO price. If earnings disappoint or sellers are aggressive, Morgan Stanley's $100 floor scenario becomes the operative discussion.

Cathie Wood of ARK Invest told Fox Business she still sees SpaceX becoming one of the most important companies in global history, pointing to its rocket launch capability and global satellite network. The market at $113.50 is not disagreeing with the long-term thesis. It is pricing in the near-term risks (Starship delays, xAI losses, and an unprecedented float expansion) that the IPO week narrative did not yet have to confront.

Loading Article...

Loading Article...